Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 23 November 2023

 
 
 
   

The future for Europe and the role of medical innovation
 
Read more on Politico.eu

"If we want our children to be first in line for future medical innovations, we need to show political will today." says Lars Fruergaard Jørgensen, EFPIA President and CEO of Novo Nordisk Global.


Imagine a future where our children and grandchildren in Europe do not fear diabetes, cancer or Alzheimer’s disease. Where these diseases can be treated in a way that means people living with them experience life like others — or where the diseases are prevented in the first place.

This might seem like a dreamer’s world. But when you think of the achievements in medicine that we take for granted on a daily basis... 

 

Read more


 
 
 
   

World AMR Awareness Week 2023

Antimicrobial Resistance threatens modern medicine as we know it. It will make routine surgeries, chemotherapy & transplants too dangerous to perform.

Unless we find a solution together to build a pipeline for future antibiotics. Discover how EFPIA is driving innovation in antimicrobials R&D.

 
 

EU pharmaceutical legislation: tackling the AMR innovation challenge for a healthier future...
20 November 2023

Confronting this complex challenge requires a comprehensive approach, encompassing enhanced surveillance, prudent use,... Read more

AMR case study: cystic fibrosis patients live in fear of infection
20 November 2023

Patient advocates in Poland are fighting to improve access to antibiotics and to enhance infection control infrastructure... Read more

AMR in Central & Eastern Europe: What do patients think?
20 November 2023

Antimicrobial resistance (AMR) is highest in central and eastern Europe ‒ we asked patient advocates how they are impacted... Read more
 
 
 
   

Events
 

DIA Innovating Clinical Trials in Europe
28 November 2023 (Virtual Event)

Must-attend virtual live conference for pharmaceutical innovators and clinical researchers alike. Read more

European Health Summit 2023
07 December 2023 (Egmont Palace, Brussels)

The 2024-2029 Agenda: The Future of Healthcare in Europe Read more
 
 
 
   

What we are reading
 
Molecules in diabetic patients could help personalise treatments
On 21 November 2023 (IHI)

IMI project RHAPSODY has identified biomarkers associated with diabetes development and progression, findings that... Read more
MSD #InsideInnovation episode
On 21 November 2023 (LinkedIn)

Why do inventors of new medicines need intellectual property? Find out from Magda Chlebus, Executive Director of... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2025 All rights reserved Disclaimer